Articles
-
Where Does Your State Stand in Texas vs. U.S.?
In Texas v. U.S., Texas and a number of other states have sued the federal government, arguing that the entire ACA should be struck down. So, where does your state stand in Texas v. U.S.?
Categorized in -
The Trump DOJ has Taken an Unexpected and Unworkable Position on the ACA
This piece describes the claim DOJ has made in regards to Texas v. U.S., attempts to unpack some of the complicated policy implications, and then considers the relevant legal issues.
Categorized in -
Considerations For Expanding International Reference Pricing Beyond Medicare Part B
Experts lay out considerations for expanding the administration’s proposed model beyond Medicare Part B drugs.
Categorized in -
Why Your Employer-Sponsored Insurance May Ultimately Not Be Good For You
Nearly 160 million Americans get insurance through employers, but that does not mean it’s good social policy.
Categorized in -
Vast Majority of Dementia Patients Don’t Receive Specialty Diagnosis and Care, Study Finds
Researchers found the use of dementia specialty care is particularly low for Hispanics and Asians.
-
Rosalie Liccardo Pacula Named Inaugural Elizabeth Garrett Chair in Health Policy, Economics, and Law
Rosalie Liccardo Pacula is a nationally recognized expert in the economics of substance use and addiction, including opioids, cannabis, and alcohol.
-
Using the Drug Pricing Netflix Model to Help States Tackle the Hep C Crisis
Researcher Neeraj Sood has explored innovative payment models as a strategy for government entities to be able to pay for lifesaving cures that could eradicate diseases like hepatitis C. Louisiana, with some input from Sood, has just implemented a modified version of a subscription model to pay for Hep C treatments.
-
Is This the Healthcare Policy Both Republicans and Democrats Can Agree On?
A mix of universal catastrophic coverage and private insurers would be cheaper than Medicare for All, Dana Goldman wrote in MarketWatch.
Categorized in -
What is Surprise Billing?
Experts from the USC-Brookings Schaeffer Initiative for Health Policy answer commonly asked questions about surprise medical bills and how to deal with them at a policy level.
Categorized in -
The Use of Vendors in Medicare Part B Drug Payment
USC-Brookings Schaeffer Initiative experts provide an analysis of a voluntary vendor approach for Medicare to restrain drug spending for Part B drugs.
Categorized in